Immunomedics (IMMU) Dr. Charles Baum to Board; Appoints Dr. Behzad Aghazadeh to Executive Chairman Replacing CEO Michael Pehl
Tweet Send to a Friend
Immunomedics, Inc., (NASDAQ: IMMU) announced that Dr. Charles Baum, President and Chief Executive Officer (CEO) of Mirati Therapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
